NMC Health plc Logo

NMC Health plc

NMMCF

(3.5)
Stock Price

0,00 USD

0% ROA

0% ROE

0x PER

Market Cap.

20.870,00 USD

0% DER

0% Yield

0% NPM

NMC Health plc Stock Analysis

NMC Health plc Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

NMC Health plc Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (20.78%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

3 PBV

With a remarkably low PBV ratio (0x), the stock offers substantial upside potential at a bargain price.

4 Revenue Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

5 Net Profit Growth

With a track record of consistent net profit growth over the past five years, this company presents a compelling investment opportunity due to its strong financial performance.

6 Assets Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

7 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

8 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (0), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

9 DER

The stock is burdened with a heavy load of debt (153%), making it financially unstable and potentially risky for investors.

10 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

11 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

NMC Health plc Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

NMC Health plc Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Buy
4 Stoch RSI Hold

NMC Health plc Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

NMC Health plc Revenue
Year Revenue Growth
2009 338.853.733
2010 386.519.662 12.33%
2011 443.746.835 12.9%
2012 490.053.000 9.45%
2013 550.878.000 11.04%
2014 643.931.000 14.45%
2015 880.870.000 26.9%
2016 1.220.835.000 27.85%
2017 1.603.396.000 23.86%
2018 2.057.253.000 22.06%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

NMC Health plc Research and Development Expenses
Year Research and Development Expenses Growth
2009 0
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

NMC Health plc General and Administrative Expenses
Year General and Administrative Expenses Growth
2009 0
2010 0 0%
2011 0 0%
2012 105.055.000 100%
2013 119.562.000 12.13%
2014 137.188.000 12.85%
2015 191.247.000 28.27%
2016 267.895.000 28.61%
2017 335.168.000 20.07%
2018 442.966.000 24.34%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

NMC Health plc EBITDA
Year EBITDA Growth
2009 39.403.853
2010 56.282.218 29.99%
2011 72.874.857 22.77%
2012 81.845.000 10.96%
2013 94.496.000 13.39%
2014 103.908.000 9.06%
2015 147.325.000 29.47%
2016 241.745.000 39.06%
2017 349.576.000 30.85%
2018 488.257.000 28.4%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

NMC Health plc Gross Profit
Year Gross Profit Growth
2009 102.551.883
2010 118.694.151 13.6%
2011 137.359.129 13.59%
2012 160.253.000 14.29%
2013 185.542.000 13.63%
2014 209.206.000 11.31%
2015 304.944.000 31.4%
2016 467.510.000 34.77%
2017 635.352.000 26.42%
2018 841.127.000 24.46%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

NMC Health plc Net Profit
Year Net Profit Growth
2009 7.620.450
2010 21.089.979 63.87%
2011 42.987.960 50.94%
2012 58.891.000 27%
2013 68.165.000 13.61%
2014 76.566.000 10.97%
2015 82.215.000 6.87%
2016 132.689.000 38.04%
2017 185.970.000 28.65%
2018 248.653.000 25.21%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

NMC Health plc Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2009 0
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 1 0%
2017 1 0%
2018 1 100%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

NMC Health plc Free Cashflow
Year Free Cashflow Growth
2009 23.464.452
2010 6.298.811 -272.52%
2011 51.052.184 87.66%
2012 -66.608.000 176.65%
2013 6.455.000 1131.88%
2014 -25.585.000 125.23%
2015 4.242.000 703.14%
2016 116.327.000 96.35%
2017 212.650.000 45.3%
2018 222.833.000 4.57%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

NMC Health plc Operating Cashflow
Year Operating Cashflow Growth
2009 60.599.795
2010 24.053.849 -151.93%
2011 71.445.085 66.33%
2012 38.669.000 -84.76%
2013 85.071.000 54.55%
2014 85.682.000 0.71%
2015 84.084.000 -1.9%
2016 176.371.000 52.33%
2017 277.511.000 36.45%
2018 387.820.000 28.44%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

NMC Health plc Capital Expenditure
Year Capital Expenditure Growth
2009 37.135.342
2010 17.755.038 -109.15%
2011 20.392.900 12.94%
2012 105.277.000 80.63%
2013 78.616.000 -33.91%
2014 111.267.000 29.34%
2015 79.842.000 -39.36%
2016 60.044.000 -32.97%
2017 64.861.000 7.43%
2018 164.987.000 60.69%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

NMC Health plc Equity
Year Equity Growth
2009 90.884.332
2010 102.980.786 11.75%
2011 100.345.129 -2.63%
2012 331.603.000 69.74%
2013 389.151.000 14.79%
2014 449.023.000 13.33%
2015 487.697.000 7.93%
2016 906.869.000 46.22%
2017 1.089.716.000 16.78%
2018 1.356.763.000 19.68%
2019 1.394.957.000 2.74%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

NMC Health plc Assets
Year Assets Growth
2009 384.285.389
2010 417.910.381 8.05%
2011 355.233.070 -17.64%
2012 715.580.000 50.36%
2013 815.262.000 12.23%
2014 950.525.000 14.23%
2015 1.453.880.000 34.62%
2016 2.316.993.000 37.25%
2017 2.939.008.000 21.16%
2018 3.872.415.000 24.1%
2019 4.981.257.000 22.26%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

NMC Health plc Liabilities
Year Liabilities Growth
2009 293.401.057
2010 314.929.595 6.84%
2011 254.887.941 -23.56%
2012 383.977.000 33.62%
2013 426.111.000 9.89%
2014 497.498.000 14.35%
2015 954.215.000 47.86%
2016 1.368.122.000 30.25%
2017 1.794.382.000 23.76%
2018 2.515.652.000 28.67%
2019 3.292.284.000 23.59%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

NMC Health plc Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
0
Price to Earning Ratio
0x
Price To Sales Ratio
0x
POCF Ratio
0
PFCF Ratio
0
Price to Book Ratio
0
EV to Sales
0
EV Over EBITDA
0
EV to Operating CashFlow
0
EV to FreeCashFlow
0
Earnings Yield
0
FreeCashFlow Yield
0
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0
Graham NetNet
0

Income Statement Metrics

Net Income per Share
0
Income Quality
0
ROE
0
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
0
EBT Per Ebit
0
Ebit per Revenue
0
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0
Return on Tangible Assets
0
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0
Current Ratio
0
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

NMC Health plc Dividends
Year Dividends Growth
2018 0
2019 0 0%

NMC Health plc Profile

About NMC Health plc

NMC Health plc provides healthcare services in the United Arab Emirates, the United Kingdom, Spain, and internationally. The company owns and manages healthcare facilities, including hospitals, medical centers, long term care facilities, day surgery centers, fertility clinics, and home health services providers. The company offers medical services comprising diagnostic, and in and outpatient services, as well as research and medical services in the field of gynecology, obstetrics, and human reproduction; and management services in respect of hospitals, as well as retails pharmaceutical goods. NMC Health plc was founded in 1974 and is based in London, United Kingdom.

CEO
Mr. David J. Hadley
Employee
17.748
Address
Devonshire House
London, W1J 8AJ

NMC Health plc Executives & BODs

NMC Health plc Executives & BODs
# Name Age
1 Mr. Santosh Marathe
Chief Operating Officer
70
2 Ms. Kate Hoffmann M.Sc., R.N.
Group Chief Nursing Officer
70
3 Mr. Stefano Sartoretti
Chief Financial Officer
70
4 Mr. Ivan Anthony
Chief Information Officer
70
5 Mr. Emeka Obiora
Vice President of Compliance & Ethics
70
6 Matthew Wells
Group General Counsel
70
7 Mr. Frank Gabriel DeLisi III
Senior Vice President of Operations – Abu Dhabi Region
70
8 Mr. Peter Menelaou
Chief Marketing & Communications Officer
70
9 Ms. Dania El Labban
Senior Vice President of Human Resources
70
10 Mr. David J. Hadley
Chief Executive Officer
70

NMC Health plc Competitors